Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00333008
Status:
UNKNOWN
Last Update Posted:
2006-09-26
First Post:
2006-05-31
Brief Title:
A Dose Study of Doxil in a Dose Dense 14 Day CDOPRituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma NHL 60 Years or With Compromised Cardiac Status
Sponsor:
The Alvin and Lois Lapidus Cancer Institute
Organization:
The Alvin and Lois Lapidus Cancer Institute
Organization Data
Organization:
The Alvin and Lois Lapidus Cancer Institute
Class:
OTHER
Study ID:
LY-012006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Alvin and Lois Lapidus Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ortho Biotech Products LP | INDUSTRY |